These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Diagnosis, management and screening of early localised prostate cancer. Selley S; Donovan J; Faulkner A; Coast J; Gillatt D Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541 [TBL] [Abstract][Full Text] [Related]
63. Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia? Hall MC; Roehrborn CG; McConnell JD Semin Urol Oncol; 1996 Aug; 14(3):122-33. PubMed ID: 8865473 [TBL] [Abstract][Full Text] [Related]
64. Costs and benefits of prostate cancer screening. Investigators of the American Cancer Society--National Prostate Cancer Detection Project. Littrup PJ; Goodman AC In Vivo; 1994; 8(3):423-7. PubMed ID: 7803728 [TBL] [Abstract][Full Text] [Related]
65. Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate. Presti JC; Carroll PR Semin Urol Oncol; 1996 Aug; 14(3):134-8. PubMed ID: 8865474 [TBL] [Abstract][Full Text] [Related]
66. Transrectal US of the prostate: is the technology leading the science? McClennan BL Radiology; 1988 Aug; 168(2):571-5. PubMed ID: 3293115 [No Abstract] [Full Text] [Related] [Previous] [New Search]